In this commentary, three pharmacy experts explain why they believe the 340B Drug Program is a needed safety net for safety net hospitals.
Bruce Thompson, Andrew Lowe, and Reid Toda
Advertisement
Articles by Bruce Thompson, Andrew Lowe, and Reid Toda
Advertisement
Latest Updated Articles
- Fighting back against 340B criticisms
Published: July 10th 2015 | Updated:
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
2
Jury Still Out on Effect of GLP-1 Drugs on the Eyes | AAO 2025
3
Understanding Keratoconus and Its Early Treatment | AAO 2025
4
Data Presented Shows AREDS Vitamins Don’t Slow Geographic Atrophy in AMD | AAO 2025
5
